Form D Explorer

Form C/A — Eliaz Therapeutics, Inc.

0002042609-26-000002 · filed 2026-03-03 · via StartEngine Primary, LLC

Offering

Target: $19,999
Maximum: $2,490,574
Security type: Other
Price per security: $5.5600
Deadline: —
Oversubscription: Accepted

Issuer

Name: Eliaz Therapeutics, Inc.
CIK: 2042609
Entity: Corporation
Jurisdiction: DE
Address: 398 Tesconi Court
Santa Rosa, CA 95401
Phone: —

Most recent fiscal year financials

Total assets

$738,015

Cash

—

Short-term debt

$2,046,085

Long-term debt

$4,188,186

Revenues

—

COGS

—

Taxes paid

—

Net income

$-954,869

View original on SEC EDGAR.